瑞来巴坦一水合物

瑞来巴坦一水合物（CAS 1174020-13-3）的独立参考数据，整理自公开化学数据库。

各数据库的登记标识

计算分子描述符

在册的记载用途

Relebactam is indicated in combination with [imipenem] and [cilastatin] for the treatment of complicated urinary tract infections (including pyelonephritis), and complicated intra-abdominal infections caused by susceptible organisms in adults.Endogenous substances and drugs that inhibit or block the activity of BETA-LACTAMASES.

同义词与商品名

Relebactam; 1174018-99-5; MK-7655; Relebactam anhydrous; (-)-Relebactam anhydrous; 1OQF7TT3PF; [(2S,5R)-7-oxo-2-(piperidin-4-ylcarbamoyl)-1,6-diazabicyclo[3.2.1]octan-6-yl] hydrogen sulfate; MK7655; Sulfuric acid mono-((2S,5R)-7-oxo-2-(piperidin-4-ylcarbamoyl)-1,6-diaza-bicyclo(3.2.1)oct-6-yl) ester; 1174020-13-3; RECARBRIO COMPONENT RELEBACTAM; MK-7655A COMPONENT RELEBACTAM; relebactamum; RECARBRIO COMPONENT RELEBACTAM MONOHYDRATE; ((2S,5R)-7-oxo-2-(piperidin-4-ylcarbamoyl)-1,6-diazabicyclo(3.2.1)octan-6-yl) hydrogen sulfate; RefChem:879223

GHS 危害分类

Reported hazard statements	H373 (100%), H412 (100%)

H373 (100%): May causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]

P260, P319, and P501 (click each P-code to see the statement)

公开数据库对它的描述

Relebactam Monohydrate · CAS 1174020-13-3 · C12H20N4O6S. UNII 1OQF7TT3PF.

物理形态与操作说明

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。